• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Diagnostics Pipeline: Company Receives NIH Grant to Develop Test for Type 1 Diabetes Progression

Diagnostics Pipeline: Company Receives NIH Grant to Develop Test for Type 1 Diabetes Progression

by Ron Shinkman | Jul 23, 2024 | Clinical Diagnostics Insider, FDA-dtet

NIH grant awarded to Metabolon is the first phase of what could be a three-year grant, according to a company official

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

Diagnostics Pipeline: Startup Women’s Health Lab Receives $4M in Federal Grants

by Ron Shinkman | Jun 27, 2024 | Clinical Diagnostics Insider, FDA-dtet

The grants, which include $3 million from the NIH and $1 million from the NSF, will help the company develop point-of-care tests

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Med-Tech Startups Survive SVB Collapse but Face New Concerns

Med-Tech Startups Survive SVB Collapse but Face New Concerns

by Glenn S. Demby | Mar 30, 2023 | Capital-lir, Essential, Laboratory Industry Report

While only time will tell how bad the ultimate damage turns out to be, it appears for now at least that the industry has dodged a bullet.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Illumina Faces Proxy Battle Over Grail Acquisition

Illumina Faces Proxy Battle Over Grail Acquisition

by Glenn S. Demby | Mar 30, 2023 | Essential, Industry Buzz-lir, Laboratory Industry Report

Carl Icahn has decided to take his beef with Illumina’s board of directors over the acquisition directly to company shareholders.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Medicare Pay Rates Are Adequate without Major Hikes, MedPAC Says

Medicare Pay Rates Are Adequate without Major Hikes, MedPAC Says

by Glenn S. Demby | Mar 29, 2023 | Essential, Laboratory Industry Report, Reimbursement-lir

Agency’s annual report to Congress concludes that providers are doing just fine and don’t need a big bump in pay at this time.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com